Abiraterone Acetate and Docetaxel With Androgen Deprivation Therapy in High-Volume Metastatic Hormone-Sensitive Prostate Cancer in China: An Indirect Treatment Comparison and Cost Analysis
Cost Effectiveness and Resource Allocation - United Kingdom
doi 10.1186/s12962-019-0193-4
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2019
Authors
Publisher
Springer Science and Business Media LLC